Cite
HARVARD Citation
Vicier, C. et al. (2021). TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients. European journal of cancer. pp. 205-214. [Online].